Growth Metrics

OmniAb (OABI) Assets Average (2021 - 2026)

OmniAb (OABI) reported Assets Average of $297.3 million for Q1 2026, down 5.88% year-over-year from $315.9 million in Q1 2025, and down 2.63% on a QoQ basis from $305.3 million in Q4 2025.

OmniAb (OABI) has 6 years of Assets Average data on file, last reported at $297.3 million in Q1 2026.

  • Quarterly Assets Average fell 5.88% year-over-year to $297.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $297.3 million (down 5.88% YoY) and the FY2025 annual result came in at $313.2 million, down 10.6% from the prior year.
  • Assets Average fell to $297.3 million in Q1 2026 per OABI's latest filing, from $305.3 million in the prior quarter.
  • Across five years, Assets Average topped out at $417.1 million in Q1 2023 and bottomed at $236.8 million in Q2 2022.
  • The 5-year median for Assets Average is $328.6 million (2024), against an average of $328.0 million.
  • The widest annual swing landed in 2022, when Assets Average soared 99.64%; it then slipped 16.08% in 2024.
  • Tracing OABI's Assets Average over 5 years: stood at $329.4 million in 2022, then grew by 16.41% to $383.5 million in 2023, then retreated by 14.32% to $328.6 million in 2024, then dropped by 7.08% to $305.3 million in 2025, then retreated by 2.63% to $297.3 million in 2026.
  • Per Business Quant, the three latest OABI Assets Average figures stand at $297.3 million (Q1 2026), $305.3 million (Q4 2025), and $302.7 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 13.04 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 33.42 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 1.72 Bn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 331.70 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 40.89 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 26.06 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - 26.03 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 40.71 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 5.05 Bn
10 OmniAb 334.72 Mn 291.75 Mn 14.41 Mn 297.28 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 297.28 Mn
Dec 31, 2025 305.30 Mn
Sep 30, 2025 302.68 Mn
Jun 30, 2025 300.93 Mn
Mar 31, 2025 315.87 Mn
Dec 31, 2024 328.56 Mn
Sep 30, 2024 334.41 Mn
Jun 30, 2024 344.91 Mn
Mar 31, 2024 363.89 Mn
Dec 31, 2023 383.47 Mn
Sep 30, 2023 398.47 Mn
Jun 30, 2023 409.14 Mn
Mar 31, 2023 417.13 Mn
Dec 31, 2022 329.41 Mn
Sep 30, 2022 237.20 Mn
Jun 30, 2022 236.85 Mn
Mar 31, 2022 270.68 Mn
Dec 31, 2021 270.73 Mn
Sep 30, 2021 118.81 Mn